Search

Catherine Ho

Examiner (ID: 13990)

Most Active Art Unit
2924
Art Unit(s)
2953, 2924
Total Applications
1329
Issued Applications
1227
Pending Applications
20
Abandoned Applications
93

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 20592468 [patent_doc_number] => 12576164 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-03-17 [patent_title] => Imidazopyrazine derivatives, process for preparation thereof, and their uses as luciferins [patent_app_type] => utility [patent_app_number] => 18/424207 [patent_app_country] => US [patent_app_date] => 2024-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 42052 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 334 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18424207 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/424207
Imidazopyrazine derivatives, process for preparation thereof, and their uses as luciferins Jan 25, 2024 Issued
Array ( [id] => 19431101 [patent_doc_number] => 20240299599 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-12 [patent_title] => DIMERIZATION STRATEGIES AND COMPOUNDS FOR MOLECULAR IMAGING AND/OR RADIOIMMUNOTHERAPY [patent_app_type] => utility [patent_app_number] => 18/515076 [patent_app_country] => US [patent_app_date] => 2023-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18623 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18515076 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/515076
DIMERIZATION STRATEGIES AND COMPOUNDS FOR MOLECULAR IMAGING AND/OR RADIOIMMUNOTHERAPY Nov 19, 2023 Pending
Array ( [id] => 19114020 [patent_doc_number] => 20240125770 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-18 [patent_title] => CELL ANALYSIS [patent_app_type] => utility [patent_app_number] => 18/243756 [patent_app_country] => US [patent_app_date] => 2023-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10203 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18243756 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/243756
CELL ANALYSIS Sep 7, 2023 Pending
Array ( [id] => 20341944 [patent_doc_number] => 12465660 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-11-11 [patent_title] => Compositions and methods for cancer imaging and radiotherapy [patent_app_type] => utility [patent_app_number] => 18/360859 [patent_app_country] => US [patent_app_date] => 2023-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 22 [patent_no_of_words] => 9979 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 141 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18360859 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/360859
Compositions and methods for cancer imaging and radiotherapy Jul 27, 2023 Issued
Array ( [id] => 19002065 [patent_doc_number] => 20240066136 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-29 [patent_title] => MODIFIED PROTEINS AND PROTEIN DEGRADERS [patent_app_type] => utility [patent_app_number] => 18/361422 [patent_app_country] => US [patent_app_date] => 2023-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 113071 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18361422 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/361422
MODIFIED PROTEINS AND PROTEIN DEGRADERS Jul 27, 2023 Pending
Array ( [id] => 19125845 [patent_doc_number] => 20240131198 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-25 [patent_title] => RATIOMETRIC BIOSENSOR TATTOOS AND USE THEREOF FOR REAL TIME MEASUREMENTS [patent_app_type] => utility [patent_app_number] => 18/225564 [patent_app_country] => US [patent_app_date] => 2023-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28119 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -64 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18225564 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/225564
RATIOMETRIC BIOSENSOR TATTOOS AND USE THEREOF FOR REAL TIME MEASUREMENTS Jul 23, 2023 Pending
Array ( [id] => 19065774 [patent_doc_number] => 20240100200 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-28 [patent_title] => COMPOSITIONS COMPRISING ASCORBIC ACID AND AN IMAGING AGENT AND RELATED METHODS [patent_app_type] => utility [patent_app_number] => 18/357073 [patent_app_country] => US [patent_app_date] => 2023-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18950 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18357073 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/357073
COMPOSITIONS COMPRISING ASCORBIC ACID AND AN IMAGING AGENT AND RELATED METHODS Jul 20, 2023 Abandoned
Array ( [id] => 18769499 [patent_doc_number] => 20230364269 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-16 [patent_title] => TOPICAL APPLICATION OF NERVE LABELING DYES FOR IMAGE-GUIDED SURGERY [patent_app_type] => utility [patent_app_number] => 18/350268 [patent_app_country] => US [patent_app_date] => 2023-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6178 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18350268 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/350268
TOPICAL APPLICATION OF NERVE LABELING DYES FOR IMAGE-GUIDED SURGERY Jul 10, 2023 Pending
Array ( [id] => 18953741 [patent_doc_number] => 20240042068 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-08 [patent_title] => CASPASE-3-TRIGGERED MOLECULAR SELF-ASSEMBLING PET PROBES AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/329245 [patent_app_country] => US [patent_app_date] => 2023-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30966 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18329245 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/329245
CASPASE-3-TRIGGERED MOLECULAR SELF-ASSEMBLING PET PROBES AND USES THEREOF Jun 4, 2023 Pending
Array ( [id] => 18673169 [patent_doc_number] => 20230310662 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-05 [patent_title] => METHODS FOR DIAGNOSING AND MONITORING EOSINOPHILIC ESOPHAGITIS [patent_app_type] => utility [patent_app_number] => 18/322854 [patent_app_country] => US [patent_app_date] => 2023-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10995 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18322854 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/322854
METHODS FOR DIAGNOSING AND MONITORING EOSINOPHILIC ESOPHAGITIS May 23, 2023 Pending
Array ( [id] => 18752536 [patent_doc_number] => 20230355814 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-09 [patent_title] => BINDING PROTEIN TARGETING HER2, PREPARATION METHOD AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/297032 [patent_app_country] => US [patent_app_date] => 2023-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9005 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18297032 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/297032
BINDING PROTEIN TARGETING HER2, PREPARATION METHOD AND USE THEREOF Apr 6, 2023 Pending
Array ( [id] => 19354029 [patent_doc_number] => 12054458 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-08-06 [patent_title] => None [patent_app_type] => utility [patent_app_number] => 18/186043 [patent_app_country] => US [patent_app_date] => 2023-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 22 [patent_no_of_words] => 9362 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18186043 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/186043
None Mar 16, 2023 Issued
Array ( [id] => 20770261 [patent_doc_number] => 12653913 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-06-16 [patent_title] => HER2 binders [patent_app_type] => utility [patent_app_number] => 18/119070 [patent_app_country] => US [patent_app_date] => 2023-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 30 [patent_no_of_words] => 7024 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18119070 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/119070
HER2 binders Mar 7, 2023 Issued
Array ( [id] => 20686630 [patent_doc_number] => 12616759 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-05-05 [patent_title] => Uses of labeled HSP90 inhibitors [patent_app_type] => utility [patent_app_number] => 18/104037 [patent_app_country] => US [patent_app_date] => 2023-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 119 [patent_no_of_words] => 61666 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18104037 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/104037
Uses of labeled HSP90 inhibitors Jan 30, 2023 Issued
Array ( [id] => 18707689 [patent_doc_number] => 20230330271 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-19 [patent_title] => THROMBUS IMAGING APTAMERS AND METHODS OF USING SAME [patent_app_type] => utility [patent_app_number] => 18/086378 [patent_app_country] => US [patent_app_date] => 2022-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7818 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18086378 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/086378
THROMBUS IMAGING APTAMERS AND METHODS OF USING SAME Dec 20, 2022 Pending
Array ( [id] => 18483638 [patent_doc_number] => 20230210939 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-06 [patent_title] => CYCLIC PEPTIDE COMPOUNDS AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 18/064677 [patent_app_country] => US [patent_app_date] => 2022-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7489 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 141 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18064677 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/064677
CYCLIC PEPTIDE COMPOUNDS AND METHODS OF USE Dec 11, 2022 Pending
Array ( [id] => 18298292 [patent_doc_number] => 20230107978 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-06 [patent_title] => High Specific Activity Preparation of F-18 Tetrafluoroborate [patent_app_type] => utility [patent_app_number] => 18/070175 [patent_app_country] => US [patent_app_date] => 2022-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10454 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18070175 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/070175
High Specific Activity Preparation of F-18 Tetrafluoroborate Nov 27, 2022 Abandoned
Array ( [id] => 20163931 [patent_doc_number] => 20250255977 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-08-14 [patent_title] => EPSILON-POLY-L-LYSINE-BASED DRUG CONJUGATE, INTERMEDIATE THEREOF, AND APPLICATION THEREOF [patent_app_type] => utility [patent_app_number] => 18/706375 [patent_app_country] => US [patent_app_date] => 2022-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34848 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -41 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18706375 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/706375
EPSILON-POLY-L-LYSINE-BASED DRUG CONJUGATE, INTERMEDIATE THEREOF, AND APPLICATION THEREOF Nov 7, 2022 Pending
Array ( [id] => 20329706 [patent_doc_number] => 12459972 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-11-04 [patent_title] => Protease-activated contrast agents for in vivo imaging [patent_app_type] => utility [patent_app_number] => 18/053682 [patent_app_country] => US [patent_app_date] => 2022-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 22 [patent_no_of_words] => 11402 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18053682 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/053682
Protease-activated contrast agents for in vivo imaging Nov 7, 2022 Issued
Array ( [id] => 18596103 [patent_doc_number] => 20230270894 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-31 [patent_title] => RADIOLABELED ANTI-LAG3 ANTIBODIES FOR IMMUNO-PET IMAGING [patent_app_type] => utility [patent_app_number] => 18/049609 [patent_app_country] => US [patent_app_date] => 2022-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33051 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18049609 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/049609
RADIOLABELED ANTI-LAG3 ANTIBODIES FOR IMMUNO-PET IMAGING Oct 24, 2022 Pending
Menu